No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
15 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
48 (estimated)
Sponsor
University of Chicago · Other
Who this trial is looking for
This trial is looking for patients aged 15 and older who have been diagnosed with acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. Participants will receive text message reminders to help them stick to their oral chemotherapy during treatment.
Are You a Good Fit for This Trial?
You may be able to join if
I am 15 years old or older.
I have been diagnosed with acute lymphoblastic leukemia.
I have been diagnosed with T-cell lymphoblastic lymphoma.
I am currently receiving treatment that includes mercaptopurine and methotrexate.
You may not be able to join if
I do not have a cell phone that receives text messages.
I do not wish to participate.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age of 15 years or older at time of enrollment
* Diagnosed with ALL or T-cell lymphoblastic lymphoma
* Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with…
Inclusion Criteria:
* Age of 15 years or older at time of enrollment
* Diagnosed with ALL or T-cell lymphoblastic lymphoma
* Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Patients in the pilot phase may have already started maintenance as long as the end of their maintenance therapy is scheduled to occur after the end of the 28-day pilot intervention.
Exclusion Criteria:
* Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
* Patient does not wish to participate
* Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
